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summary
1. Incubation of decarboxyfactor X with the factor X-activating enzyme
from Russell's Viper venom revealed the generation of amidase activity towards
Bz-IIe-Glu-Gly-Arg-pNA, but not of activity in blood coagulation.
2."Ihe rate of activation of both factor X and decarboxyfactor X depends
on the ability of the zymogens to bind ca2*. The relationship between ca2*
concentration and velocity of the activation reaction is sigmoid in the case of
factor X, but hyperbolic with decarboxyfactor X.
3. Activated decarboxyfactor X was purified by powder column electro-
phoresis.
4. Identical changes of primary structure accompanied the activation of fac-
tor X and decarboxyfactor X. Identica-l molecular weight and common anti-
genic determinants were found in factor Xu and decarboxyfactor Xu. The
amino acid composition was identical except for 12 glutamic acid residues in
decarboxyfactor X. and 7-carboxyglutamic acid residues in factor Xu.
5. Unlike factor X, activated factor X has a very low electrophoretic mobil-
ity in the presence of Ca2* at pH 8.6. This is probably due to self association of
factor x, under the influence of ca2*. The electrophoretic mobility of
activated decarboxyfactor X is only slightly decreased compared to decarboxy-
factor X in the presence of Ca2*.
Introduction
'Two 
alternative modes of activation of factor X exist in the physiological
blood coagulation process: the' extrinsic and intrinsic systems. The extrinsic
pathway'requires tissue thromboplastin and factor VII [1-5]. Via the intrinsic
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pathway factor X is activated by a product of activated factor 
IX, factor VIII'
phospholipids and Ca2* [6--1]'l ' 
! 1
several ,,on_prrysiological modes of activation of factor 
X have also been
described, util izing Russlll 's Viper venom t12-161 and try-psin [17'18]'
Recent studies 14,,13,141shtwed that the conversion of 
factor X (molecular
weight bb g00) tolutto, x" nv factor IXu and factor VIII, 
factor VII and tissue
f a c t o r , a p r o t e a s e f r o m R u s s e l l ' s v i p e r u " t ' t o - o r p a n c r e a t i c t r y p s i n , i s d u e t o
"i"uuugu 
of ,an activation peptide from the NH2-terminal region of 
the heavy
chain. This cleavage occurs between Arg-51 and IIe-52, 
giv-ing rise to factor ̂ Xuo
(molecular weight 47 2OO) and an activation peptide (molecular 
weight 8700)'
Factor Xuo is convertqd into factor XuB (molecular weight 
44 200) by hydroly-
s i s o f a s e c o n d p e p t i d e b o n d b e t w e e n A r g , 2 g 0 a n d G l y - 2 9 1 a t t h e C - t e r m i n a l
region of the heavy chain. Factor Xuo and factor X^B have-equivalent 
coagulant
activity. Factor X activated by one of ttt" agents described 
above is the protein
that contributes the active site to prothrombinase, the 
physioiogical activator
of prothrombin consisting of factor Xu, factor V, phospholipids, 
and ca'?* [19]'
pactor X. alone has a small prothrombinase activity'
Unlike factor X, decarboxyfactor X lacks the ability to 
bind Caz*, and does
not function normally in blotd coagulation [43]. To determine 
whether this is
because decarboxyfa"tor x cannot be split by factor X activating 
agents or
because ,,activated" decarboxyfactor X ii still inactive in 
prothrombinase is the
purpose of this article.
Materials and Methods
Al lchemica lswe leana ly t i ca lg tadeandobta inedf romMerck .Fac torXand
decarboxyfactor X were obtained according to the purification 
procedures
r e p o l t e d e a r l i e r [ ' 2 0 ] . C r u d e R u s s e l l ' s V i p e r v e n o m w a s o b t a i n e d f r o m S i g m a
chemical co., St. Louis, u.s.A. and the factor X activator 
from it was purified
by.the method of schif iman [24]; i t  wi l l  be designated "vipervenom"in 
the
rest of the article. The chromogenic substrate Bz-Ile-GIu-GIy-Arg-pNA 
(s-2222)
w a s ' ' a k i n d g i f t o f D r . G . C l a e s o n ( A . B . B o f o r s N o b e l D i v i s i o n , P e p t i d e
Research, Miilndal, Sweden). p-Nitrophenylguanidino-benzoate 
(NPGB) was
purchased from Biochemical Nutrition Corp'
Amino acid.snd NH2-terminal amino acid analysis
, ,The' arnino acid composition was determined 
by means of the method
a c c o ; d ' i n g t o S p a c k m a n " [ 2 5 ] . A m i n o t e r m i n a l a m i n o a c i d a n a l y s i s w a s p e r -
fo rmedaccord ing toGray |26 l .yCarLroxyg lu tamicac idwasdeterminedwi th
the method of Zytkovici t-211. tr,lore detaiti about the analysis 
were reported
earlier [ 20].
Protein concentrution determination
Concent ra t ionof to ta lp ro te in inso lu t ionswasdeberminedbyabsorbanceat
280 nm, arsrrminj-Aih i" t  factor X=L2'4 [28] '  The same 
value could be
,used for o"ter-irratio., of decarboxyfactor X concentration 
because the
molecular weight and amino,acid composition for Jactor x 
and decarboxyfac-
tor, X are equivalent- An Al!s-^ of 10'O was employed 
for the venom coagu-
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lant protein'[15] and A'r30.^ of 12.2 for factor Xu and decarboxyfactor X.
l ze l .
Gel electrophoresis :
Analytical polyacrylamide gel electrophoresis, disc-gel electrophoresis in.the
presence of sodium dodecyl sulphate and agarose gel electrophoresis were per-
formed as reported earlier [20].
I mmuno chemical metho ds
The one-dimensional crossed immunoelectrophoresis, employed for
decarboxyfactor X determination using monospecific antibovine factor X anti-
serum, was performed using the method of Laurell [30] as reported earlier
[20]. Double immunodiffusion was performed according to Ouchterlony [31].
Fqclor Xo assay
Factor X was activated in suitable mixtures as described under Materials and
Methods. At intervals, 10-pl aliquots were removed from the'activatioh mix-
tures and diluted with 1.0 ml Michaelis buffer containing 10 mM EDTA. The
samples were further diluted with Michaelis buffer depending on the degree of
activation. Subsequently, an aliquot (0.1 m) of the final dilution was incubated
at 37" C for 30s with 0.1 'ml cephalin prepared from bovine brain with the
method of Bell and Alton [32], and 0.1 ml factor X-deficient bovine plasrna
obtained as described in ref. 23. clotting was initiated by adding 0.1mI of 33
mM CaCl2 solution to the incubation mixture. The clotting times were con-l
verted into units obtained by a reference curve of the logarithm of clotting
time against the logarithm of dilutions of activated factor X. One unit factor
X" activity per ml was defined as the activity of 10 pg factor X^ per ml, i.e.,
about the amount that can be qenerated in 1 ml norrnal plasma.
Actiue site titration
Titration of factor Xu and decarboxyfactor Xa with NPGB was performed,
according to Smith [33]. In a typical titration the sample cuvette contains
0.3 mg per ml of factor Xu or decarboxyfactor Xu in 0.1 M sodium barbital, pH
8.3, with a final volume of 300 pl. The reference cuvette contains the same
volume of buffer solution alone. To each cuvette 10,rrl of a 0.01 M solution of
NPGB in dimethylformamideacetonitrile (1 : 3, v/v) was added simultaneously.
The reaction was followed at 4L0 nm in an Aminco DW-2 spectro-
photometer at 25" C. The concentration of p-nitrophenol released during the
reaction was calculated from the zero time intercepi of the extrapolated steady
state absorbance. In the Aminco DW-2 spectrophotometer Aa16 for p-nitro-
phenol at pH 8.3 was calculated as 17 500.
Amiduse actiuity assay
The amidase activity of activated factor X and activated decarboxyfactor X
was measured according to Svendsen et al. [34]. At intervals, 10-pl aliquots
were removed from the incubation mixture and diluted with 90 1rl of 0.05 M
Tris ' HCI/0.05 M imidazole buffer (pH 8.3) containing 0.1 M Nacl and 10 mM
EDTA. To obtain a final volume of''350 1tt, 320 pl 0.0b M Tris . HCI/O.05 M
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im{dazole;buffer (pH 8.3) containing 0.1 M'NaCl, 25 pl solutibn of Bz-Ile-Glu-
GIy-Arg-pN A (S-2i22) in water (2 mM) and 5 pl of the diluted sample were
mixed. The initial rate of hydrolysis was measured in an Aminco DW-2 spectro-
photometer, operating in the dual wavelength mode. Analysis was conducted at
b7'C and amidase activity is expressed as AA3nr-.oo/min'
Rate of conuersion of factor X and decarboxyfactor X
The following incubation procedule was used when factor X and decarboxy-
factor X were activated by viper venom. Buffer solution of 0.05 M Tris 
' HCi/
0.0b M imidazole 1pH 8.5),  containing 0.1 M NaCl,  Russel l 's Viper venom-X,
3-2222 and factor X or decarboxyfactor X was added to a microcuvette (Helma
type 105 OS with 10 mm lightpath). The final concentrations of the reaction
ctmponents are.given in the legend to Fig.3. The endogenousrate of hydroly-
sis of 3-2222 *u, ^"urrred before the reaction was initiated by addition of
Ca2*. All assays were performed in an Aminco DW-2 spectrophotometer oper-
ating in the dlal waveiength mode. The hydrolysis of 3-2222 wasmeasured at
391 nm with 344 nm as the reference wavelength. The determination was
carried oUt at 37" C and amidase activity was expressed as A.n,-roo/min'
Preparation of Factor Xo
A solution containinf 48 mg of factor X and 120 ml of 0.025 M Tris 
' HCI
buffer (pH 8.3), 0.2 Nt in Nacl was made 5 mM with respect to cacl, and
ir,".rnut"a at 87;C for B0 min with 0.8 mg of the factor X-converting protein
from Russell's viper venom. complete activation of factor X was achieved as
judged by factor Xu activity assay of the incubation mixture. The reaction mix-
iure was-then diluted twice with 0.05 M Tris 
' HCI (pH 7.1) containing 0.06 M
trisodium citrate and dialyzed overnight against the same buffer. Then the
incubation mixture *u, uppli"d to a column (30 x 1.5 cm) of DEAE-Sephadex
equilibrated in the dialysis buffer. Factor Xu was eluted as a single peak by a
linear NaCl gradient (0-0.6 M) in 0.05 M Tris ' HCI buffer (pH B'0) containing
0.1 M trisodium citrate.
PreBarati,on of actiuated decarboxyfactor X
Semi-purified decarboxyfactor X obtained after QAE-Sephadex chromatog-
,upfry 1iO1 was dialyzed against 0,025 M Tris 'HCl buffer,p;17.4, 
containing
O.i if4 NaCl. Decarboxyfactor X, 40 mg in 25 ml of dialysis buffer,  ̂ was
incubated with 1 mg Russell's Viper venom in the presence of 10 mM Ca2* aL
37'C for 100 min. The reaction was stopped by the addition of EDTA to a
final concentration of 10 mM. The reaction mixture was then dialyzed against
2 mM Tris ' glycine buffer, pH 8.3, containing 1 mM EDTA' Activated
decarboxyfactor X was isolated by powder column electrophoresis according
to Rosentaum [35]. All buffers contained 5mM calcium lactate, in order 
to
obtain a separation tetween decarboxyfactor Xu and residual amounts of factor
Xu. The column of the LKB 7900 Uniphor apparatus was packed with a slurry
oiBioget p-300 (100-200 mesh) in 0.025 M Tris 'glycine buffer,  pH 8.3. First ,
a,uoltJme of 2b ml of 0.02b M Tris' HCI buffer, pH 8.2, was allowed to flow
into the column and then the sample (30 mg protein dissolved in 25 ml Tris 
'
HGI buffer). After the sample had entered the column, Tris/glycine buffer'
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pH 8.3, was placed on the top of the column.,A potential difference of 600 v
was applied and the power was'maintained at 16 w throughout the course of
the separation. The sample was eluted from the bottom of the column with
Tris ' glycine buffer, pH 8.3, at a flow rate of B0 ml per h. Fractions of B ml
were collected. Decarboxyfactor Xu was determined by amidase assay as
described elsewhere.
Results
Actiuation of bouine factor x and decarboxyfactor x by Russell's viper uenom
The generation from purified factor X of coagulant factor Xu activity and
amidase activity upon action of Viper venom is shown in Fig. 1-A. The weight
ratio of venom to factor X in this experiment was 1 : 80. The results shows a
good agreement between formation of factor Xu activity and amidase activity.
The reaction is essentially complete within 3,min. It is,also demonstrated that
EDTA completely inhibits the activation reaction
Fig. 18 shows the same experiment with decarboxyfactor X instead of factor
X. For the' activation of decarboxyfactor X the weight ratio of decarboxy-
factor X to Viper venom was 50 : 1. In contrast to an almost negligible forma-
tion of factor X^ activity within 2 min, a progressive increase in amidase activ-
ity is demonstrated. The small factor X" activity generated by viper venom
from decarboxyfactor X activity is most likely due to a contamination of fac-
tor X (less than 57o). IJnder the conditions used, decarboxyfactor X is almost
completely activated within 150 min. As in the activation of factor x, EDTA
inhibits the reaction completely. The final yield of amidase activity per mol of
zymogen with decarboxyfactor X is about 907o of that obtained with factor X.
, Molecular weight changes in factor X and decarboxyfactor X upon activation
were monitored by sodium dodecyl sulphate (SDS) gel electrophoresis. with
2 4 6 8 10 40 80 .t2O 160.
incubat ion  t ime (min)  incubat ion  t ime (min)
Fig. 1. Activation of factor X and decarboxyfactor X by Viper venom. A. Factor X (0.8 mg/ml) was incu-
bated with Viper venom (f O pglmi) and Ca2+, 1o mM final concentration. B. Decaboxyfactor X (1.O mgl
ml) was incubated with viper venom ,(25 trrg/ml) and ca2+, 10 mM final concentration. o€, Factor
Xu activitV as determined by bioassay; o-o, amidase activity towuds Bz-Ite-Glu-Gly-Arg-pNA;
A 4 ,  amidase ac t iv i t y ,  ac t i va t ion  cdr ied  ou t  in  the  presence o f  10  mM EDTA.
--i
f.
. a
o
12O q.
a z t
factor X the protein band of the original protein decreases in intensity 
during
the first minutes of activation. Parallel *ittt tt'," disappearance of 
this band a
new, faster moving protein band appears' Appearance of the latter 
coincides
with the generatron of factor Xu and amidase activity (Fig' 1), 
and can be
assigned to factor X.* [4]. At loriger incubation time a slightly 
faster moving
protein band was uilo-otrn-ed, this will be referred to as factor 
X"p [41'
Because the Xu actrvity and amidase activity remain unchanged, factors 
Xuo and
XuB have the same specific activity'
hualitatively, the same molecular changes as described 
for factor X were
observed in decarboxyfactor X upon incubation with vrper venom' 
The appear-
ance of a new faster moving piotein band coincided with the 
generation of
amidase activity. Both occuried at a slower rate with decarboxyfactor 
X than
with factor X.
Influence of Ca2' on rute of actiuation of factor X and decarboxyfactor 
X by
Viper uenom
The rate of factor X and decarboxyfactor X activation by viper 
venom was
m e a s u r e d b y a c o n t i n u o u s s p e c t r o p h o t o m e t r i c a s s a y a S d e s c r i b e d u n d e r
Materials and Methods. In the case of a linear rate of factor Xu 
or decarbg"v-
factor X. formatron, the increase of amidase activity towards Bz-Ile-Glu-Gly-
Arg-pNA will be parabolic in time. A plot of absorbance velsus 
f2 yields a
strirgt-rt line, the siope of which indicates the initial velocity of 
the activation
reaction [36]. The linear relationship between absorbance 
ancl t2 obtained from
activation experiments at variable Ca" concentrations is shown 
in Fig' 2'
The effect of Oa2* on the initial rate of the activation of factor 
X and decar-
boxyfactor X by Viper venom is summarized in Fig' 3' It is shown 
that under
optimal conditions ifr" initiut rate of factor Xu formation is about 
60 times
higher than the initial rate of decarboxyfactor Xu formation' 
of particular
interest in these studies were the differences in nature of the Cat* 
dependence:
sigmoid and hyperbolic in case of factor X and decarboxyfactor 
X activation'
r"'rpe"tiuety (erg s) The Hill plot (Fig.4) of the data presented 
in Figs. 3A
and BB suggests cooperativity and .ro.r-"oop"tativity in the Ca2*-dependent
activation of factor X and decarboxyfactor X, respectively.
Preparation of actiuated factor X
Factor X. was sepaiated from the activation mixture described 
under
M a t e r i a l s a n d M e t h o a s n y a s i n g l e s t e p o f D E A E - S e p h a d e x c h r o m a t o g r a p h y .
conversion of factor Xuo into factor x.B t+] could be stopped 
by addition of
trisodium citrate. when EDTA was used instead, it was found 
to precipitate
factor Xu with considerable loss of activity. Precipitation 
of protein material
during the incubation was observed when factor X concentrations 
greater than
S 0 0 p g p e r m I w e r e u s e d i n t h e a c t i v a t i o n m i x t u r e ' T h i s i s p r o b a b l y d " " - t 1 1 "
Ca2*-mediated agglegation of factor X.. Factor Xu was- eluted 
from the DEAtr-
Sephadex column af a Nacl concentration of 0.24M in asingle 
peak. The fac-
to rXupreparedby th ismethodcanbeprac t ica l l yhomog_eneous,as isshownby
disc gel electrophoresis. It is furtheruho*rt that factor Xu has 
a higher electro-
p h o r e t i c m o b i l i t y t h a n f a c t o r X ( F i g . 5 ) . T h e s p e c i f i c a c t i v i t y o f t h e b e s t
ir"p*u6orrs as ietermined by bioassay was 
found to be 3.0' 10s U/mg pro-
o
o
o
c
o
0
o
o
o
c
L
o
30 40
t2 (min)
Fig. 2. The effect of Cal on factor X and decarboxyfactor X activation by Viper venom. A.,The time
courses of activatiori of factor X. Factor x, 13 pglml was incubated with viper venom. o.12 pgiml in thepresence of Bz-Ile-Glu-Glv-Axg-pNA (1.1 '1o-4 M). The final concentration of cab ln ttre actiJation mix-
tu re  was:  * ,  none i  o ,  0 .6  mM;  . ,  O.Z  mM;  ^ ,  O.g  mMi  a ,  1 .O mM;  r ,  1 . .b  mM;  D,  2 .g  mM;  X,  b .6  mM.
tein. The functional enzyme concentration as determined by NPGB titration
was about 90vo of the actual protein concentratigri (b.b . 10-u M).
Preparation of actiuated decarboxyfactor X
The activation procedure of decarboxyfactor X was performed as described
3341
\
{ 5 .
g
o
< 4
I
oo
1 . O  2 . O  3 . 0  4 0  5 u  o v
Ciz . (mM) -Ca2 ' (mM)
Fie. 3. Rate of generation of amidase 
activitv from factor X (A) and decarboxvfactor 
X (B) with Viper
;.:;;;;;;"; ca2+ concentrations' as determined 
trom Fig'.2'
under Materials and Methods. After maximal amidase 
activity was formed'
ac t iva teddecarboxy fac torXwaspur i f ied f romtheact iva t ionmix tu reby
powder column electrophoresis with continuous elution. 
ca2* was present in
-3.4 - 3.2
rog lcazl ul
F ig ' 4 .H i [ p l o to f t heda tap resen ted inF ig .SAandB ,whe reu i s t he in i t i a l ve l oc i t ya tanyCa2+concen -
tration, V is the ititi.r t"ro"ivl;;;;;t 
concentrationi open circies' factor x; closed cilcles' 
decar'
b o x y f a c t o r , X .  
: :  i  ) :
L
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i
)
)
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Fig. 5. Polyacrylamide disc gel electrophoresis of purif ied factor X." and decarboxyfactor Xu..GeI 1: fac'
tor X, 5O ltg; gel 2i factor X2, 50 pgi gel3: decarboxyfactor X, 5O pgi gel 42 decarboxyfactor Xa, 30 pg.' .
the electrophoresis buffer in order to, decrease the electrophoretric mobility
of factor X. which may be,present.as:a contarnination in the activation,h.ix-
, ' i '  i  :  I  . .  t  \  
:  .  "
The :relevant ,part of the elution profile of the electrophoresis,,is dhown in
Fig.6. The protein peak around fraction 145 contained,amidase,activityrand
was found to crossreact with monospecific anti-bovine factor X antiserum. The
<
o
o
1 F
N
U
I
A ./t^'
71 ,-ut'J 
\r/
-l 
'J 
,/*\
90 100 110 120 130 140 150 160 170 180
fraction number
Fig, 6. Puri.fication of activated decaboxyfactor X by.;preprative powder co.lumn electrophoresis. Experi-
mental conditions as descdbed under methods. o, Protein (A2gOr-), .,,amidase actlvity towards Bz-Ile-
qlu-Gly-Arg-.trNA; t.d., tracking dye (bromophenol blue). '  
. '  
. :
D J O
decarboxyfactor Xu-containing fractions were pooled and concentrated to
about 5 ml (Amicon PM-10 mernbrane).
The final yield is about 307o, as calculated from recovery of protein reacting
with antifactor X. The specific activity was determined b5 bioassay for factor
X. activity was approximately 6 ' 102 U/mg protein. This is less than 77o of the
specific activity generally determined for purified factor X^. The functional
decarboxyfactor Xu concentration as assayed by NPGB titration was about 75%
of the calculated protein concentration. The activated decarboxyfactor X pre-
pared by this method in a good preparation is homogeneous in polyacrylamide
gel electrophoresis and has, in absence of Ca2', an electrophoretic mobility
equal to factor X^ (Fig. 5).
Zone electrophoresis of factor Xo and decarboxyfactor Xo
We performed an electrophoresis in agarose gel at pH 8.6 in the presence of
EDTA or Ca2*. Factor Xu and decarboxyfactor Xu have identical electro-
phoretic mobilities which are somewhat lower than that of factor X in the pres-
ence of EDTA. In the plesence of Ca2* , factor Xu has a very low electro-
phoretic mobility and even tends to migrate to the cathode. The electro-
phoretic mobility of decarboxyfactor X. is retarded in the presence of Ca2* .
Immunodiffusion
In double immunodiffusion experiments according to Ouchterlony [31]
single precipitation lines were observed for anti-factor X against activated fac-
tor X and activated decarboxyfactor X. Reactions of partial identity were
observed. The results indicate that the two proteins have antigenic determi-
nants in common (Fig. 7).
6
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Fig. 7. Double immurodiffusion. Centre
bgvine plasma; wellr 2, factor X; well 3,
fac to r  X ;  we l l  6 ,  decaboxy fac tor  Xa.
well contained anti-bovine factor X antiserum. Well 1, normal
factor'Xa; well 4, coumain bovine plasma; well 5, decuboxy-
t
3Bt
Polyacrylamide gel electrophoresis in the ptresence of sodium dodecyt sulphate
Electrophoresis of purified factor X" and decarboxyfac{or Xu on polyacryl-
amide in the presence of sodium dodecyl sulphate according to Weber and
Osborn [37] shows that both enzymes have an identical molecular weight of
about 47 400 (Fig. B, gels 1 and 3). Electrophoresis after disulfide reduction
demonstrates that the proteins consist of two polypeptide chains with molecu-
lar weights around 36 000 and 1"8 000 (Fig. 8, gels 2 and 4). A comparison with
reduced factor X or reduced decarboxyfactor X indicates that the moleculdr
change by activation with Viper venom occurs by splitting off a peptide from
the heavy chain. The molecular weight of the light chain remains unchanged in
the activation process. Especially in less pure preparations, as used for this
experiment, conversion of the a-form into the p-form of the (pro)enzyme can
blur the bands.
Aminoterminal amino acid analysis
Aminoterminal amino acid analysis was performed with the method according
to Gray [26]. For both factor Xu and decarboxyfactor Xu alanine and iso-
leucine were found as the aminoterminal amino acids. Earlier, alanine was
reported as the aminoterminal amino acid of the light chain vrhile tryptophane
was probably the aminoterminal acid of the heavy chain of decarboxyfactor X
[20]. It is obvious that after activation of decarboxyfactor X isoleucine
becomes the new aminoterminal amino acid of the heavv chain. as is the case
with factor X [13].
Amino acid analysis
The amino acid compositions for factor Xu and decarboxyfactor Xu are
summarized in Table I. No significant differences in amino acid composition
foctor Xo
heavy choin
choin
Fig. 8, Sodium dodecyl sulphate polyacrylamide gel electrophoresis. Gel 1, factor Xa, lb rJg; gel 2,lactor
Xa, 30 pg, disulfide reduced prior to electrophoresis; gel 3. decaboxyfactor xa, 15 pg; gel 4, d.ecarboxy-
factor X., 30 /.rg, disulfide reduced prior to electrophoresis.
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TABLE  I
AMINO ACID COMPOSITION OF FACTOR Xa AND 
DECARBOXYFACTOR Xa
Amino acid Factor  
Xa
moi /47  OO0
D ecdboxy '
fac to r  Xa
mol /47  OO0
Factor  Xuq * *+
Mv-47 OOO
Lysine
Histidine
Arginine.
Aspartic acid
Threonine *
Serine *
Glutamic acid
Proline
Glycine
Alanine
Half-cystine
Valine
Methionine
Isoleucine
Leucine
Tyrosine
Phenylalanine
7-Carboxyglutamic acid 
* *
+ Va-lues detemined bv extrapolatio L to zero time 
hvdrolysis'
*+  Detemined m an acrd  hydro lysa te  a f te r  reduc t ion  
o f  the  p lo te in  w i th  [3H]d ibo lme '
+*+  Detemined f rom amino ac id  compos i t ion  f2 l '221 '
weleobserved.Theseaminoac idana lysesa le in fa i r l ygoodagTeementwi th the
data from the known amino acid composition [13'2\'221'
"y-Carboxyglutamate residues wer; determined with 
a modified method
according to Zytkovic z l27l as described in ref. 20. The 
numbel of 7-calboxy-
glutamate residues detected in factor Xu was about the same 
as in factor X'
indicating that no 7-carboxyglutamate residues wele lost 
during the activation
and subsequent pudfication Lf factor X.. I,ess than one 
residue of 7-carboxy-
glutamate iesidue was found per mol decarboxyfactor Xa'
Discussion
In th isa l t i c leexper imentsa ledescr ibedbywhichwedemonst ra te thecon.
version of decarboxyfactor X into an activ; enzyme analogous 
to factor-X.'
preliminary commu;ications of this phenomenon were made by us earlier [38'
3e l .
The aim of the experiments was to determine whether 
the inability of decal-
boxyfactor X to participate in blood c.oagulation is due 
to an impaired activation
mechanism and/or impaired enzymatic function in 
prothrombinase'
T h e S y n t h e t i c c h r o m o g e n i c s u b s t r a t e , B z - I l e . G l u - G l y - A r g - p N A h a s b e e n
shown to be a useful tool in studying the reactions 
involved in activation of fac-
tor X [40,41]; it ars" upp"ur"d su;table 
for studying the activation of decar-
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I D
3 8
26
l l
9
27
8
4 l
2 7
5 8
1-2
3 8
2 5
1 8
6
l 1
26
o
2 l
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2 2
8
2 2
3 8
26
25
1 3
44
2 8
1 1
1 9
6
9
2 6
I
2 L
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boxyfactor X.
In contrast to activation
to IXu, the activation of
by the physiological activators, factor VII^ and fac-
faltor X by Viper venom does not require phos-
3 3 9
pholipids [4]. However, the mechanism of activation of factor X by physiol-
ogical and non-physiological activators has been shown to be identical [41.
Under the conditions used, factor X was completel5r activated within three
minutes and clotting and amidase activity increased in parallel (Fig. 1a). Under
the same conditions the complete activation of decarboxyfactor X, as measured
by amidase activity, requires about 180 min (Fig. 1B).
After that time about the same amidase activity as in the factor X activation
was reached. The possibility of converting decarboxyfactor X in an enzyme
analogous to factor Xu was also confirmed by the comparable time course of
generation of amidase and the limited proteolysis as visualized by SDS gel
electrophoresis. The time course of generation of clotting activity is qualita-
tively and quantitatively quite different in the two preparations. Therefore, it is
concluded that no clotting activity can be generated from decarboxyfactor X.
The small amount of factor Xu activity generated from decarboxyfactor X must
be due either to a contamination by factor X and/or to a small endogenous fac-
tor X activity of decarboxyfactor Xu (see below).
To our surprise the activation of decarboxyfactor X depends on the presence
of Ca2* . This Ca2* requirement is unexpected because it is known that the fac-
tor X activating fraction of Viper venom binds no ca2* I42f , and decarboxy-
factor X has a very low affinity for caz*, due to the absence of 7-carboxy-
glutamate residues [43]. It was shown that the maximal rate of factor X activa-
tion is about 60 times higher than of decarboxyfactor X, whereas the velocity
of activation of factor X is dependent upon Ca2* concentration in a sigmoidal
fashion; that of decarboxyfactor X is hyperbolic.
A Hill plot of the data obtained indicates that only in the case of factor X
the increase in Ca2* concentration has a positive cooperative effect on the reac-
t ion  ve loc i ty  (n r=  4 .3 ) .
we conclude that the substrate for Russell's viper venom-X is the protein
complexed with caz* and that ca2* binding to 7-carboxyglutamate residues is
essential for a rapid conversion to factor Xu.
In view of the Hill coefficients obtained it is tempting to speculate that a
Ca2*-induced conformational change in factor X is important for the activation
reaction. Evidence for a Ca2*-dependent conformation in factor X was obtained
by ultraviolet difference spectroscopy analysis [43]. The fact that addition of
Ca2* to decarboxyfactor X has no effect on the spectra of the aromatic amino
acids and the low rate of activation of decarboxyfactor X clearly demonstrates
the importance of a Ca2*-dependent conformational change in the substrate for
a rapid activation.
From the Caz' binding experiments it is assumed that cooperativity in the
ca2*-dependent activation of factor X is caused by a positive cooperative
binding of the first four calcium ions to factor X I4Bl. However, the concentra-
tion of ca2', 2 mM, required for a maximal rate of activation of factor X sug-
gests that in addition to the occupancy of the Ca2* binding sites mentioned
above, a second set of sites must be filled. This interpretation is consistent with
the observation of Prendergast and Mann [44] who showed that the maximal
rate of activation of prothrombin is found at a Ca2* concentration which
greatly exceeds that required to fill tlne Caz' binding sites which exhibit posi-
tive cooperativity.
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r Separation of activated factor X from the activation mixture could be
achieved ,by DEAE-sephadex chromatography as described by Jesty [45] .
Using this procedure we did not succeed in separating activated decarboxyfac-
tor X from its activation mixture. Using powder column electrophoresis a
homogeneous preparation, as judged by polyacrylamide electrophoresis, could
be obtained. Addition of Ca2* to the electrophoresis buffer was carried out in
order to obtain a separation between decarboxyfactor X. and contaminating
factor Xu. In spite of this, a residual factor Xu activity (about 6 
' 10'z U/mg pro-
tein) can be detected in the purif ied decarboxyfactor Xu preparation. The pres-
ence of factor X. activity in the purif ied product may be due to a persistant
contamination or to an intrinsic activity of decarboxyfactor Xu, as in the case
of decarboxyfactor II t461. Differentiation wil l only be possible when high
yietds of decarboxyfactor Xu enable us to carry out rigorous tests for purity of
this product.
As measured by sodium dodecyl sulphate gel electrophoresis, factor Xu and
decarboxyfactor Xa have equal molecular weights. Fig. 8 suggests that two
forms of the enzymes may exist with molecular weights of approximately
47 000 and 43 000. Upon reduction prior to electrophoresis it is shown that
the heterogeneity is due to a difference in molecular weight of the heavy chain.
Because the only aminoterminal amino acids found were isoleucine and alanine,
the difference must be caused by splitt ing off a peptide at the carboxyterminal
end of the heavy chain. These results are consistent with the two forms of fac-
tor Xu reported by Fujikawa [14] and Jesty [47]. Further proof for the con-
version of decarboxyfactor X into an active enzyme analogous to factor Xu was
obtained by an immunological technique and amino acid analysis. It has been
shown that decarboxyfactor Xu and factor Xu have common antigenic deter-
minants (Fig. 7). Important differences in amino acid composition were only
found with respect to 7-carboxyglutamate content (Table I). Moreover, the
7-carboxyglutamate content of factor Xu is unaltered as compared 
with factor
X. This result indicates that all 7-carboxyglutamate residues are conserved after
activation by Viper venom. A striking difference of electrophoretic mobil ity of
factor X. and factor X was found in the plesence of Ca2'. The most l ikely
explanation for this phenomenon might be the tendency of factor Xu to aggre-
gaie in the presence of Ca2* [45]. AIso the electrophoretic mobil ity of decar-
boxyfactor X., in the presence of Ca2*, is somewhat decreased. Whether this
can be due to aggregation is not yet clear.
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